{"0P00000E7S.F": {"short_name": "Ibercaja Sanidad A FI", "long_name": "Ibercaja Sanidad A FI", "currency": "EUR", "summary": "La gesti\u00c3\u00b3n toma como referencia la rentabilidad del \u00c3\u00adndice 60 % * MSCI World Health Care USD + 35% * MSCI Europe Health Care Index + 5% Simult\u00c3\u00a1nea mes Zona Euro Exposici\u00c3\u00b3n, directa o indirectamente (m\u00c3\u00a1ximo 10% a trav\u00c3\u00a9s de IIC), de al menos un 75% en renta variable de empresas dedicadas al cuidado de la salud, incluido equipamiento sanitario, aprovisionamientos sanitarios, distribuidores de productos, proveedores de servicios, gestores y due\u00c3\u00b1os de instalaciones como hospitales, centros de la 3\u00c2\u00aa edad, etc, proveedores de tecnolog\u00c3\u00ada, compa\u00c3\u00b1\u00c3\u00adas biotecnol\u00c3\u00b3gicas, compa\u00c3\u00b1\u00c3\u00adas farmace\u00c3\u00baticas y las relacionadas con otras actividades de investigaci\u00c3\u00b3n, desarrollo y producci\u00c3\u00b3n de f\u00c3\u00a1rmacos.", "manager_name": "Not  Disclosed", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "Ibercaja Gesti\u00c3\u00b3n SGIIC", "exchange": "FRA", "market": "dr_market"}, "0P00000PK1.F": {"short_name": "Caixabank Multisalud Estandar ", "long_name": "Caixabank Multisalud Estandar FI", "currency": "EUR", "summary": "La gesti\u00c3\u00b3n toma como referencia la rentabilidad del \u00c3\u00adndice MSCI World Health Care. Entre el 75% y el 100% de la exposici\u00c3\u00b3n ser\u00c3\u00a1 en valores de renta variable, cotizados en mercados autorizados, de compa\u00c3\u00b1\u00c3\u00adas del sector de la salud. Estas inversiones se materializan en valores de baja, media y/o, fundamentalmente, alta capitalizaci\u00c3\u00b3n burs\u00c3\u00a1til y se dirigen principalmente al mercado americano y europeo complementado con algunas de las compa\u00c3\u00b1\u00c3\u00adas japonesas m\u00c3\u00a1s importantes. La inversi\u00c3\u00b3n m\u00c3\u00a1xima en activos de pa\u00c3\u00adses emergentes ser\u00c3\u00a1 del 15%. La exposici\u00c3\u00b3n a riesgo divisa podr\u00c3\u00a1 superar el 30%.", "manager_name": "Jordi  Mas", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "Caixabank Asset Management SGIIC", "exchange": "FRA", "market": "dr_market"}, "0P00000QBA.F": {"short_name": "BSO Bio Sant\u00e9 C", "long_name": "BSO Bio Sant&#195;&#169; C", "currency": "EUR", "summary": "L\u00e2\u0080\u0099objectif de gestion est la recherche d\u00e2\u0080\u0099une performance sup\u00c3\u00a9rieure, sur la dur\u00c3\u00a9e de placement recommand\u00c3\u00a9e de cinq ans, \u00c3\u00a0 cel le de l\u00e2\u0080\u0099indicateur de r\u00c3\u00a9f\u00c3\u00a9rence, \u00c3\u00a0 savoir l\u00e2\u0080\u0099indice MSCI World Health Care en euro, calcul\u00c3\u00a9 dividendes net r\u00c3\u00a9investis.\nL\u00e2\u0080\u0099indicateur sert de r\u00c3\u00a9f\u00c3\u00a9rence \u00c3\u00a0 posteriori : la gestion de l\u00e2\u0080\u0099OPCVM n&#39;\u00c3\u00a9tant pas indicielle, sa performance pourra, le cas \u00c3\u00a9ch\u00c3\u00a9ant, s&#39;en \u00c3\u00a9carter sensiblement.", "manager_name": "R\u00c3\u00a9my  Plantevin", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "Saint Olive Gestion", "exchange": "FRA", "market": "dr_market"}, "0P00006AEW.TW": {"short_name": "Prudential Financial Global Bio", "long_name": "Prudential Financial Global Bio-Health Fund TWD", "currency": "TWD", "summary": "The fund invests primarily in healthcare and biotechnology companies listed on the stock exchanges of Taiwan and overseas.", "manager_name": "Yi Qian  Jiang", "manager_bio": "\u00e5\u00ad\u00b8\u00ef\u00a6\u008c\u00ef\u00bc\u009a\u00e7\u00be\u008e\u00e5\u009c\u008b\u00e5\u0096\u00ac\u00e6\u00b2\u00bb\u00e8\u008f\u00af\u00e7\u009b\u009b\u00e9\u00a0\u0093\u00e5\u00a4\u00a7\u00e5\u00ad\u00b8\u00e5\u0095\u0086\u00e5\u00ad\u00b8\u00e7\u00a2\u00a9\u00e5\u00a3\u00ab\n\u00e6\u00b7\u00a1\u00e6\u00b1\u009f\u00e5\u00a4\u00a7\u00e5\u00ad\u00b8\u00e7\u00b6\u0093\u00e6\u00bf\u009f\u00e7\u00b3\u00bb\n\u00e7\u00b6\u0093\u00ef\u00a6\u008c\u00ef\u00bc\u009a2000.8-\u00e8\u00bf\u0084\u00e4\u00bb\u008a \u00e4\u00bf\u009d\u00e5\u00be\u00b7\u00e4\u00bf\u00a1\u00e6\u008a\u0095\u00e4\u00bf\u00a1\u00e7\u00b6\u0093\u00ef\u00a7\u00a4\n1995.1-1998.5 \u00e6\u0097\u00a5\u00e5\u0095\u0086\u00e5\u00a4\u00a7\u00e5\u0092\u008c\u00e8\u00ad\u0089\u00e5\u0088\u00b8\u00e7\u00a0\u0094\u00e7\u00a9\u00b6\u00e5\u0093\u00a1", "category": "Sector Equity Healthcare", "family": "Prudential Financial Sec Inv Trust Ent", "exchange": "TAI", "market": "tw_market"}, "0P00006HYY.SI": {"short_name": "United Global Healthcare Fund -", "long_name": "UOB United Global Healthcare Fund SGD Acc", "currency": "SGD", "summary": "The investment objective of the Fund is to achieve long term capital growth by investing in securities issued by companies principally involved in the development, production or distribution of products, equipment and/or services related to healthcare, in any part of the world. Such investments would include investing in sub-sectors of the healthcare industry such as medical products, health services, major pharmaceuticals, specialty major pharmaceuticals, and specialty pharmaceuticals.", "manager_name": "Not  Disclosed", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "UOB Asset Management Ltd", "exchange": "SES", "market": "sg_market"}, "0P0000HLYB.F": {"short_name": "Albemarle Longevity Fund Class", "long_name": "Albemarle Longevity Fund Class A", "currency": "EUR", "summary": "Albemarle Longevity Fund is an open-end fund incorporated in Ireland. The Fund aims to achieve long term capital appreciation by investing in stocks which could benefit the most from the long-term demographic trend of ageing population. The Fund will have a predominant exposure to Europe.", "manager_name": "Not  Disclosed", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "Albemarle Asset Management Ltd", "exchange": "FRA", "market": "dr_market"}, "0P0000U1SX.F": {"short_name": "Albemarle Longevity Fund Class", "long_name": "Albemarle Longevity Fund Class I", "currency": "EUR", "summary": "Albemarle Longevity Fund is an open-end fund incorporated in Ireland. The Fund aims to achieve long term capital appreciation by investing in stocks which could benefit the most from the long-term demographic trend of ageing population. The Fund will have a predominant exposure to Europe.", "manager_name": "Not  Disclosed", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "Albemarle Asset Management Ltd", "exchange": "FRA", "market": "dr_market"}, "0P0000U2IC.F": {"short_name": "Ibercaja Sanidad B FI", "long_name": "Ibercaja Sanidad B FI", "currency": "EUR", "summary": "La gesti\u00c3\u00b3n toma como referencia la rentabilidad del \u00c3\u00adndice 60 % * MSCI World Health Care USD + 35% * MSCI Europe Health Care Index + 5% Simult\u00c3\u00a1nea mes Zona Euro Exposici\u00c3\u00b3n, directa o indirectamente (m\u00c3\u00a1ximo 10% a trav\u00c3\u00a9s de IIC), de al menos un 75% en renta variable de empresas dedicadas al cuidado de la salud, incluido equipamiento sanitario, aprovisionamientos sanitarios, distribuidores de productos, proveedores de servicios, gestores y due\u00c3\u00b1os de instalaciones como hospitales, centros de la 3\u00c2\u00aa edad, etc, proveedores de tecnolog\u00c3\u00ada, compa\u00c3\u00b1\u00c3\u00adas biotecnol\u00c3\u00b3gicas, compa\u00c3\u00b1\u00c3\u00adas farmace\u00c3\u00baticas y las relacionadas con otras actividades de investigaci\u00c3\u00b3n, desarrollo y producci\u00c3\u00b3n de f\u00c3\u00a1rmacos.", "manager_name": "Not  Disclosed", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "Ibercaja Gesti\u00c3\u00b3n SGIIC", "exchange": "FRA", "market": "dr_market"}, "0P0000XTT7.F": {"short_name": "Trecento Sant\u00e9 ISR R EUR", "long_name": "Trecento Sant&#195;&#169; ISR R EUR", "currency": "EUR", "summary": "Trecento Sant\u00c3\u00a9 ISR est un fonds qui investit en actions de soci\u00c3\u00a9t\u00c3\u00a9s internationales issues du secteur de la sant\u00c3\u00a9 (notamment les laboratoires pharmaceutiques, les biotechnologies, le mat\u00c3\u00a9riel m\u00c3\u00a9dical, les services de sant\u00c3\u00a9) et ce sans r\u00c3\u00a9f\u00c3\u00a9rence \u00c3\u00a0 un indice. Le fonds Trecento Sant\u00c3\u00a9 ISR a pour objectif d\u00e2\u0080\u0099offrir une performance annuelle sup\u00c3\u00a9rieure \u00c3\u00a0 7% nette de frais pour les parts \u00c2\u00ab R EUR \u00c2\u00bb, \u00c2\u00ab R CHF \u00c2\u00bb et \u00c2\u00ab R USD \u00c2\u00bb et sup\u00c3\u00a9rieure \u00c3\u00a0 8% nette de frais pour la part \u00c2\u00ab I EUR \u00c2\u00bb. Cet objectif de performance est associ\u00c3\u00a9 \u00c3\u00a0 un objectif de gestion extra-financier visant \u00c3\u00a0 exclure les soci\u00c3\u00a9t\u00c3\u00a9s aux pratiques ESG (Environnement, Social, Gouvernance) contestables (via une politique d\u00e2\u0080\u0099exclusion normative et sectorielle) et \u00c3\u00a0 s\u00c3\u00a9lectionner les soci\u00c3\u00a9t\u00c3\u00a9s affichant les meilleures pratiques ESG \u00e2\u0080\u0093 approche \u00c2\u00ab best-in-class \u00c2\u00bb.", "manager_name": "Alice  Lhabouz", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "Trecento Asset Management", "exchange": "FRA", "market": "dr_market"}, "0P00016BB7.HK": {"short_name": "BOCIP China Health Care Fund A", "long_name": "BOCIP China Health Care Fund A", "currency": "HKD", "summary": "The Sub-Fund seeks to provide investors with long-term capital appreciation by investing in securities that design, make or sell products and services related to health care industry in the People\u00e2\u0080\u0099s Republic of China (\u00e2\u0080\u009cPRC\u00e2\u0080\u009d). Such theme-specific securities include companies in the PRC (i) that are engaged in pharmaceuticals, biotechnology, medical devices or technology,surgical research or equipment, healthcare provision and consultation, health or nutrition\nsupplements research or production, ownership and/or management of or provision of services relating to hospitals, nursing homes or health maintenance organizations, infancy care centres or after-life service organizations; or (ii) companies having their major business activities related or connected to healthcare sector.", "manager_name": "Not  Disclosed", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "BOCI-Prudential Asset Management Ltd", "exchange": "HKG", "market": "hk_market"}, "SELJLP.MI": {"short_name": "SELECTRA J. LAMARCK PHARMA CLAS", "long_name": "Selectra Investments Sicav - J Lamarck Pharma D", "currency": "EUR", "summary": "The main objective of this Sub-Fund is to profit from increasing share prices in the pharmaceutical sector worldwide. The focus is on mature top tier pharmaceutical companies and companies with interesting pipeline of products in development in a single or numerous markets. The followed investment policy will enable the Sub-Fund to increase overall return by active stock selection of companies, offering the most promising technology platform.", "manager_name": "", "manager_bio": "", "category": "Sector Equity Healthcare", "family": "SELECTRA MANAGEMENT COMPANY S.A.", "exchange": "MIL", "market": "it_market"}}